Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23494728)

1.

Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study.

Tagalakis V, Tamim H, Blostein M, Hanley JA, Kahn SR.

Cancer Causes Control. 2013 Jun;24(6):1079-85. doi: 10.1007/s10552-013-0185-1. Epub 2013 Mar 15.

PMID:
23494728
2.

Use of warfarin and risk of urogenital cancer: a population-based, nested case-control study.

Tagalakis V, Tamim H, Blostein M, Collet JP, Hanley JA, Kahn SR.

Lancet Oncol. 2007 May;8(5):395-402.

PMID:
17466896
3.

The effect of warfarin use on clinical stage and histological grade of prostate cancer.

Tagalakis V, Tamim H.

Pharmacoepidemiol Drug Saf. 2010 May;19(5):436-9. doi: 10.1002/pds.1943.

PMID:
20437456
4.

Validating a method that deals with missing drug information in the Saskatchewan Drug Plan database.

Tamim HM, Tagalakis V.

Pharmacoepidemiol Drug Saf. 2009 Feb;18(2):140-6. doi: 10.1002/pds.1692.

PMID:
19090502
5.

Molecular markers and death from prostate cancer.

Concato J, Jain D, Uchio E, Risch H, Li WW, Wells CK.

Ann Intern Med. 2009 May 5;150(9):595-603.

PMID:
19414838
6.

Advancing age within established Gleason score categories and the risk of prostate cancer-specific mortality (PCSM).

Russo AL, Chen MH, Aizer AA, Hattangadi JA, D'Amico AV.

BJU Int. 2012 Oct;110(7):973-9. doi: 10.1111/j.1464-410X.2012.11470.x.

PMID:
22954029
7.

Low-dose aspirin and survival in men with prostate cancer: a study using the UK Clinical Practice Research Datalink.

Cardwell CR, Flahavan EM, Hughes CM, Coleman HG, O'Sullivan JM, Powe DG, Murray LJ.

Cancer Causes Control. 2014 Jan;25(1):33-43. doi: 10.1007/s10552-013-0306-x. Epub 2013 Dec 6.

PMID:
24310109
8.

Vasectomy and prostate cancer: a case-control study in India.

Platz EA, Yeole BB, Cho E, Jussawalla DJ, Giovannucci E, Ascherio A.

Int J Epidemiol. 1997 Oct;26(5):933-8.

9.

Antidepressants and risk of prostate cancer: a nested case-control study.

Tamim HM, Mahmud S, Hanley JA, Boivin JF, Stang MR, Collet JP.

Prostate Cancer Prostatic Dis. 2008;11(1):53-60. Epub 2007 Aug 7.

PMID:
17684479
10.

Initial management of prostate-specific antigen-detected, low-risk prostate cancer and the risk of death from prostate cancer.

Aizer AA, Chen MH, Hattangadi J, D'Amico AV.

BJU Int. 2014 Jan;113(1):43-50. doi: 10.1111/j.1464-410X.2012.11789.x. Epub 2013 Mar 8.

PMID:
23473327
11.

Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancer.

Chamie K, DeVere White RW, Lee D, Ok JH, Ellison LM.

Cancer. 2008 Nov 1;113(9):2464-70. doi: 10.1002/cncr.23695.

12.

Family history and prostate cancer risk in a population-based cohort of Iowa men.

Cerhan JR, Parker AS, Putnam SD, Chiu BC, Lynch CF, Cohen MB, Torner JC, Cantor KP.

Cancer Epidemiol Biomarkers Prev. 1999 Jan;8(1):53-60.

13.

Screening for prostate cancer.

Ilic D, Neuberger MM, Djulbegovic M, Dahm P.

Cochrane Database Syst Rev. 2013 Jan 31;1:CD004720. doi: 10.1002/14651858.CD004720.pub3. Review.

PMID:
23440794
14.

Increased non-prostate cancer death risk in clinically diagnosed prostate cancer.

van Leeuwen PJ, Otto SJ, Kranse R, Roobol MJ, Bul M, Zhu X, de Koning H, Schröder FH.

BJU Int. 2012 Jul;110(2):188-94. doi: 10.1111/j.1464-410X.2011.10811.x. Epub 2012 Jan 30.

PMID:
22288823
15.

Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.

Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.

Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.

PMID:
19554969
16.

Vasectomy and prostate cancer: a case-control study in a health maintenance organization.

Zhu K, Stanford JL, Daling JR, McKnight B, Stergachis A, Brawer MK, Weiss NS.

Am J Epidemiol. 1996 Oct 15;144(8):717-22.

17.

Long-term survival in a Swedish population-based cohort of men with prostate cancer.

Sandblom G, Dufmats M, Varenhorst E.

Urology. 2000 Sep 1;56(3):442-7.

PMID:
10962312
18.

Early detection of high-grade prostate cancer using digital rectal examination (DRE) in men with a prostate-specific antigen level of <2.5 ng/mL and the risk of death.

Hattangadi JA, Chen MH, D'Amico AV.

BJU Int. 2012 Dec;110(11):1636-41. doi: 10.1111/j.1464-410X.2012.11354.x. Epub 2012 Jul 3.

PMID:
22757982
19.

A cohort study investigating aspirin use and survival in men with prostate cancer.

Flahavan EM, Bennett K, Sharp L, Barron TI.

Ann Oncol. 2014 Jan;25(1):154-9. doi: 10.1093/annonc/mdt428.

20.

Serum vitamin D and risk of prostate cancer in a case-control analysis nested within the European Prospective Investigation into Cancer and Nutrition (EPIC).

Travis RC, Crowe FL, Allen NE, Appleby PN, Roddam AW, Tjønneland A, Olsen A, Linseisen J, Kaaks R, Boeing H, Kröger J, Trichopoulou A, Dilis V, Trichopoulos D, Vineis P, Palli D, Tumino R, Sieri S, Bueno-de-Mesquita HB, van Duijnhoven FJ, Chirlaque MD, Barricarte A, Larrañaga N, González CA, Argüelles MV, Sánchez MJ, Stattin P, Hallmans G, Khaw KT, Bingham S, Rinaldi S, Slimani N, Jenab M, Riboli E, Key TJ.

Am J Epidemiol. 2009 May 15;169(10):1223-32. doi: 10.1093/aje/kwp022. Epub 2009 Apr 9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk